• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HE Zhuohui,WU Jixu,GAO Pengfei,ZHANG Chenggui,YU Rongmin,HU Xuqiao.Research progress on molecular mechanisms of Chinese materia medica targeted therapy for malignant melanoma[J].Journal Of Pharmaceutical Research,2025,44(5):480-490,516[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2088times   Download 771次 QR Code for this article
Scan with your phone!
中药靶向抗恶性黑色素瘤分子机制研究进展
何卓慧1,2,吴季栩2,高鹏飞1,张成桂1,于荣敏2,3,胡绪乔3
Font:Larger+|Default|Smaller-
(1.大理大学药学院,云南 大理 671000;2.暨南大学中药生物技术研究所,广东 广州 510632;3.深圳市慢性病防治中心/深圳市皮肤病防治研究所,广东 深圳 518020)
摘要:
恶性黑色素瘤(malignant melanoma,MM)源自黑色素细胞,具有高度侵袭性,近年来的发病率与死亡率均呈现上升趋势。中药及天然药物通过干预信号通路、细胞周期阻滞、促进凋亡及血管内皮新生等分子机制,对MM发挥干预或治疗作用,显示出独特的治疗特点。本文在调研国内外文献的基础上,对近年来MM生成的主要分子机制、中药靶向治疗MM的分子机制及应用进行了述评与分析,旨在为临床治疗MM和改善预后提供科学依据。
关键词:  恶性黑色素瘤  中药  靶向治疗  分子机制
DOI:10.13506/j.cnki.jpr.2025.05.011
基金项目:广东省医学科学技术研究基金项目(No.A2024128)
Publication Date:May 25, 2025
Research progress on molecular mechanisms of Chinese materia medica targeted therapy for malignant melanoma
HE Zhuohui1,2,WU Jixu2,GAO Pengfei1,ZHANG Chenggui1,YU Rongmin2,3,HU Xuqiao3
(1.School of Pharmacy, Dali University,Dali 671000,China;2.Biotechnological Institute of Chinese Materia Medica, Jinan University,Guangzhou 510632,China;3.Shenzhen Center for Chronic Disease Control, Shenzhen Institute of Dermatology, Shenzhen 518020,China)
Abstract:
Malignant melanoma (MM) originates from melanocytes and exhibits high aggressiveness, with increasing incidence and mortality rates in recent years. Chinese materia medica (CMM) and their bioactive constituents have demonstrated unique therapeutic characteristics in intervening or treating MM through molecular mechanisms, such as interfering with signaling pathways, cell cycle arrest, promoting apoptosis, and angiogenesis. This article surveyed domestic and international literatures, and commented on and analyzed the main molecular mechanisms of MM oncogenesis, as well as the molecular mechanisms and application of CMM-based targeted therapy for MM. The aim is to provide a scientific basis for clinical treatment of MM and improving prognosis.
Key words:  Malignant melanoma  Traditional Chinese medicine  Targeted therapy  Molecular mechanism
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.